Two infections treated together under the CDC's 2021 guidelines, then a California rule deciding what can reach an untested partner: the NU576 STI plan handles both halves. Searches like "nu 576 unit 8 assignment example", "nu576 unit 8 sample" and "nu576 unit 8 example" land here.
Two Positive Results From One Swab: An STI Management Plan for Chlamydia and Gonorrhea, With Expedited Partner Therapy Under California Law
[Student Name]
Purdue University Global
NU576: NP II - Primary Care of Women's Health
Unit 8 STI Management Plan
[Instructor Name]
[Date]
The patient is a composite; doses, dates and results are bracketed and follow the cited guidelines.
Findings
Ms. [A.], 26, a dental assistant, presented with [five] days of increased vaginal discharge. Vaginal swab NAAT: positive for Chlamydia trachomatis and Neisseria gonorrhoeae. Urine pregnancy test: negative. Temperature [36.9] C. Pelvic exam: mucopurulent cervical discharge; no cervical motion, uterine or adnexal tenderness. Pelvic inflammatory disease was considered and is not present. Weight [68] kg. No drug allergies.
Problem 1: Gonorrhea
Treatment: [ceftriaxone 500 mg] intramuscularly, once, the regimen recommended for uncomplicated gonorrhea in people weighing less than 150 kg (St. Cyr et al., 2020; Workowski et al., 2021). Given in clinic today. Test of cure: not required for uncomplicated urogenital infection treated with the recommended regimen; retest at three months.
Problem 2: Chlamydia
Pregnancy: negative, which permits doxycycline. Treatment: oral [doxycycline 100 mg], one tablet morning and evening for seven days, the recommended regimen for chlamydia in people who are not pregnant (Workowski et al., 2021). Azithromycin would be the alternative if she were pregnant or unable to complete a seven-day course. Ceftriaxone treats the gonorrhea and doxycycline is there because chlamydia is confirmed, not as a routine add-on; when chlamydia is excluded, gonorrhea is treated with ceftriaxone alone.
Problem 3: Partner Management
Expedited partner therapy, providing medication or a prescription for a patient's partner without an examination, is permitted in California by statute for chlamydia, gonorrhea and trichomoniasis (Cal. Health & Safety Code § 120582, 2024). The CDC maintains a state-by-state page on its legal status, and its guidelines support expedited partner therapy for heterosexual partners of patients with chlamydia or gonorrhea when the partner is unlikely to seek care (Workowski et al., 2021).
Packet for her partner:
1. Medication: a single oral dose of [cefixime 800 mg], plus the same seven-day [doxycycline] course she is taking.
2. Written instructions for taking both.
3. Warning symptoms that call for in-person care: testicular pain or swelling, fever, or symptoms that do not resolve.
4. Advice to be tested for HIV and syphilis and to see a clinician.
5. Advice to avoid sex for a week after his last dose and until any symptoms clear.
Problem 4: Preventing Reinfection
Both she and her partner abstain from sex until seven days after both have completed treatment and any symptoms have resolved. Condoms afterward. She was told that reinfection is common when a partner is not treated.
Problem 5: Other Testing and Vaccines
HIV and syphilis testing today. Hepatitis B: vaccinated in childhood [documented]. HPV: completed series [documented]. Hepatitis C: screened [two] years ago, negative.
Problem 6: Doxycycline Postexposure Prophylaxis
Not offered. The CDC's 2024 guidance limits its doxycycline postexposure prophylaxis recommendation to gay, bisexual and other MSM and to transgender women who had a bacterial STI in the past year, and does not extend the recommendation to cisgender women, because a trial in cisgender women did not show benefit (Bachmann et al., 2024).
Follow-Up
1. Retest for chlamydia and gonorrhea at three months, because reinfection is common; sooner if symptoms return.
2. Call in [three] days to confirm her partner received and took the medication.
3. Reporting: chlamydia and gonorrhea are reportable conditions in California; the case report is sent to the local health department within the required timeframe.
What She Was Told
Both infections are common, curable and often cause no symptoms, so her partner may be infected without knowing it. She was told that the shot today treats one infection and the tablets treat the other, that she needs to finish all fourteen tablets even if the discharge clears in two days, and that stopping early is a common reason infections return. Doxycycline can upset the stomach and increase sun sensitivity, so she should take it with food and water, remain upright for a while after each dose, and use sunscreen. She asked whether the infection could affect her ability to have children later. The answer was that untreated infections can, which is exactly why treating both of them now, and her partner, matters, and that she has no signs of the pelvic infection that causes that damage.
She was also told how the partner packet works in practice: she can give it to her partner herself, or, if that feels unsafe, the clinic can help notify him anonymously through the health department. She chose to give it herself, and she agreed that the clinic could call her in three days to check that he had taken it.
Why This Order
The plan starts with findings that exclude pelvic inflammatory disease, since that would change the regimen and the urgency, and ends with the public health obligation. In between, partner management gets the most space because it is the step most often missed, and an untreated partner is the most common reason a treated patient returns with the same infection.
References
Bachmann, L. H., Barbee, L. A., Chan, P., Reno, H., Workowski, K. A., Hoover, K., Mermin, J., & Mena, L. (2024). CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recommendations and Reports, 73(2), 1-8. https://doi.org/10.15585/mmwr.rr7302a1
Cal. Health & Safety Code § 120582 (2024).
St. Cyr, S., Barbee, L., Workowski, K. A., Bachmann, L. H., Pham, C., Schlanger, K., Torrone, E., Weinstock, H., Kersh, E. N., & Thorpe, P. (2020). Update to CDC's treatment guidelines for gonococcal infection, 2020. Morbidity and Mortality Weekly Report, 69(50), 1911-1916. https://doi.org/10.15585/mmwr.mm6950a6
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1-187. https://doi.org/10.15585/mmwr.rr7004a1
How this NU576 Unit 8 example is structured
Each organism is handled in its own subsection before the combined regimen appears, so the reader sees that ceftriaxone treats gonorrhea and doxycycline is there for chlamydia, not as a routine add-on. A pregnancy result sits directly above the regimen because it decides between doxycycline and the alternative. Partner management gets the longest section. It states that expedited partner therapy is permitted in California by statute, notes that the CDC keeps a state-by-state legal status page, and lists what the partner's packet contains: medication, instructions, warning symptoms and advice to seek testing. The paper adds one sentence explaining why doxycycline postexposure prophylaxis is not offered: the CDC's 2024 guidance did not extend its recommendation to cisgender women. Follow-up, retesting and reporting close the plan, each with a timeframe.
Get an NU576 Unit 8 example written to your instructions
Name the state your NU576 prompt uses; the case text and rubric should come too. The management plan follows the 2021 CDC regimens, each agent and amount inside brackets, and sets partner treatment under that state's own rules. Its patient is invented, its turnaround 24-48h, and nobody pays the first time. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
NU576 Unit 8 questions, answered
Is expedited partner therapy legal everywhere?
No. It is permissible in most states, but rules differ on which infections it covers and which clinicians may provide it, and a few states restrict it. The CDC maintains a legal status page for each state. Your plan should name the state in the prompt and state its rule instead of assuming permission.
Why does the plan retest at three months if treatment works?
Because reinfection is common, often from an untreated partner, and the 2021 guidelines recommend retesting about three months after treatment for both chlamydia and gonorrhea. A test of cure is a different thing, needed in specific situations such as pharyngeal gonorrhea or pregnancy. Graders notice when the two are confused.
Should the plan include HIV prevention?
A brief assessment is usually expected, because a bacterial STI is a marker of possible HIV exposure. Recording HIV testing and, where risk warrants it, a discussion of preexposure prophylaxis shows awareness of the wider picture. Keep it proportionate to the case, and bracket any agent named. A sentence on why doxycycline postexposure prophylaxis does not apply to her also shows current knowledge.